Meta-analysis of the correlation between selenium and incidence of hepatocellular carcinoma

Oncotarget

Volumn 7, Issue 47, 2016, Pages 77110-77116

  Zhang, Ziwei ^a   Bi, Mingyu ^b   Liu, Qi ^a   Yang, Jie ^a   Xu, Shiwen ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b Harbin Railway Public Security Bureau police dog base   (China)

Author keywords

Correlation; Hepatocellular carcinoma; Meta analysis; Selenium

Indexed keywords

SELENIUM;

ARTICLE; ASIAN; CANCER INCIDENCE; CASE CONTROL STUDY; CAUCASIAN; COHORT ANALYSIS; CORRELATION ANALYSIS; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; RISK ASSESSMENT; SELENIUM BLOOD LEVEL; SYSTEMATIC REVIEW; ADULT; AGED; BLOOD; DEFICIENCY; FEMALE; INCIDENCE; LIVER TUMOR; MALE; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; SELENIUM; YOUNG ADULT;

EID: 84998865466     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12804     Document Type: Article

References (27)

1. Liu JG, Zhao HJ, Liu YJ, Liu YW, Wang XL. Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats. J Trace Elem Med Biol. 2012; 26: 255-61.
2. Rohr-Udilova N, Sieghart W, Eferl R, Stoiber D, Björkhem-Bergman L, Eriksson LC, Stolze K, Hayden H, Keppler B, Sagmeister S, Grasl-Kraupp B, Schulte-Hermann R, Peck-Radosavljevic M. Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma. Hepatology. 2012; 55: 1112-21.
3. Kasaikina MV, Turanov AA, Avanesov A, Schweizer U, Seeher S, Bronson RT, Novoselov SN, Carlson BA, Hatfield DL, Gladyshev VN. Contrasting roles of dietary selenium and selenoproteins in chemically induced hepatocarcinogenesis. Carcinogenesis. 2013; 34: 1089-95.
4. Moustafa ME, Carlson BA, Anver MR, Bobe G, Zhong N, Ward JM, Perella CM, Hoffmann VJ, Rogers K, Combs GF, Schweizer U, Merlino G, Gladyshev VN, et al. Selenium and selenoprotein deficiencies induce widespread pyogranuloma formation in mice, while high levels of dietary selenium decrease liver tumor size driven by TGFa. PLoS One. 2013; 8:e57389.
5. Maki A, Kono H, Gupta M, Asakawa M, Suzuki T, Matsuda M, Fujii H, Rusyn I. Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Ann Surg Oncol. 2007; 14:1182-90.
6. Konishi M, Iwasa M, Araki J, Kobayashi Y, Katsuki A, Sumida Y, Nakagawa N, Kojima Y, Watanabe S, Adachi Y, Kaito M. Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. J Gastroenterol Hepatol. 2006; 21: 1821-5.
7. Novotny L, Rauko P, Kombian SB, Edafiogho IO. Selenium as a chemoprotective anti-cancer agent: reality or wishful thinking. Neoplasma. 2010; 57:383-91.
8. Gong HY, He JG, Li BS. Meta-analysis of the association between selenium and gastric cancer risk. Oncotarget. 2016; 7:15600-5. doi: 10.18632/oncotarget.7205.
9. Yao HD, Wu Q, Zhang ZW, Li S, Wang XL, Lei XG, Xu SW. Selenoprotein W serves as an antioxidant in chicken myoblasts. Biochim Biophys Acta. 2013; 1830:3112-20.
10. Yao HD, Wu Q, Zhang ZW, Zhang JL, Li S, Huang JQ, Ren FZ, Xu SW, Wang XL, Lei XG. Gene expression of endoplasmic reticulum resident selenoproteins correlates with apoptosis in various muscles of se-deficient chicks. J Nutr. 2013; 143:613-9.
11. Chin-Thin W, Wei-Tun C, Tzu-Ming P, Ren-Tse W. Blood concentrations of selenium, zinc, iron, copper and calcium in patients with hepatocellular carcinoma. Clin Chem Lab Med. 2002; 40:1118-22.
12. Kim IW, Bae SM, Kim YW, Liu HB, Bae SH, Choi JY, Yoon SK, Chaturvedi PK, Battogtokh G, Ahn WS. Serum selenium levels in Korean hepatoma patients. Biol Trace Elem Res. 2012; 148: 25-31.
13. Tashiro H, Kawamoto T, Okubo T, Koide O. Variation in the distribution of trace elements in hepatoma. Biol Trace Elem Res. 2003; 95: 49-63.
14. Kolachi NF, Kazi TG, Afridi HI, Kazi NG, Khan S. Investigation of essential trace and toxic elements in biological samples (blood, serum and scalp hair) of liver cirrhotic/cancer female patients before and after mineral supplementation. Clin Nutr. 2012; 31: 967-73.
15. Yu SY, Zhu YJ, Li WG, Huang QS, Huang CZ, Zhang QN, Hou C. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res. 1991; 29: 289-94.
16. Casaril M, Corso F, Bassi A, Capra F, Gabrielli GB, Stanzial AM, Nicoli N, Corrocher R. Decreased activity of scavenger enzymes in human hepatocellular carcinoma, but not in liver metastases. Int J Clin Lab Res. 1994; 24: 94-7.
17. Lin TH, Tseng WC, Cheng SY. Direct determination of selenium in human blood plasma and seminal plasma by graphite furnace atomic absorption spectrophotometry and clinical application. Biol Trace Elem Res. 1998; 64:133-49.
18. Kazi TG, Kolachi NF, Afridi HI, Kazi NG, Sirajuddin, Naeemullah, Arain SS. Effects of mineral supplementation on liver cirrhotic/cancer male patients. Biol Trace Elem Res. 2012; 150:81-90.
19. Yu MW, Horng IS, Hsu KH, Chiang YC, Liaw YF, Chen CJ. Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am J Epidemiol. 1999; 150:367-74.
20. Bettinger D, Schultheiss M, Hennecke N, Panther E, Knüppel E, Blum HE, Thimme R, Spangenberg HC Selenium levels in patients with hepatitis C virus-related chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma: a pilot study. Hepatology. 2013; 57:2543-4.
21. Sakoda LC, Graubard BI, Evans AA, London WT, Lin WY, Shen FM, McGlynn KA. Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China. Int J Cancer. 2005; 115:618-24.
22. Yu SY, Zhu YJ, Li WG. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res. 1997; 56:117-24.
23. Lin CC, Huang JF, Tsai LY, Huang YL. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Biol Trace Elem Res. 2006; 109:15-24.
24. Hughes DJ, Duarte-Salles T, Hybsier S, Trichopoulou A, Stepien M, Aleksandrova K, Overvad K, Tjønneland A, Olsen A, Affret A, Fagherazzi G, Boutron-Ruault MC, Katzke V, et al. Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr. 2016; 104:406-14.
25. Gorozhanskaia éG, Sviridova SP, Dobrovol'skaia MM, Zybrikhina GN, ShR K. [Selenium and oxidative stress in cancer patients]. Biomed Khim. 2013; 59:550-62.
26. DI SM, Volpe MG, Colonna G, Nazzaro M, Polimeno M, Scala S, Castello G, Costantini S. A possible predictive marker of progression for hepatocellular carcinoma. Oncol Lett. 2011; 2:1247-1251.
27. Li W, Zhu Y, Yan X, Zhang Q, Li X, Ni Z, Shen Z, Yao H, Zhu J [The prevention of primary liver cancer by selenium in high risk populations]. Zhonghua Yu Fang Yi Xue Za Zhi. 2000; 34:336-8.